Processa pharmaceuticals to present at the biotech showcase 2024

Hanover, md, jan. 02, 2024 (globe newswire) -- processa pharmaceuticals, inc. (nasdaq: pcsa) (“processa” or the “company”), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients suffering from cancer, announces that george ng, chief executive officer, will present a corporate overview at the biotech showcase 2024. the event is being held at the hilton san francisco union square on january 8 – 10, 2024.
PCSA Ratings Summary
PCSA Quant Ranking